The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. 2005

Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
Centre for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.

The main (M) group of human immunodeficiency virus type 1 (HIV-1) is responsible for the global AIDS epidemic while HIV-1 group O (outlier) and HIV type 2 are endemic only in west and central Africa. The failure of HIV-2 and especially HIV-1 group O to spread following the initial zoonotic jumps is not well understood. This study was designed to examine the relative replicative capacities between these human lentiviruses. A pairwise competition experiment was performed with peripheral blood mononuclear cells with eight HIV-2 isolates, 6 group O viruses, and 15 group M viruses of subtype A (2 viruses), B (5 viruses), C (4 viruses), D (2 viruses) and CRF01_AE (2 viruses). HIV-1 group M isolates of any subtype were typically 100-fold-more fit than group O or HIV-2 strains when competed in peripheral blood mononuclear cells from various humans. This order in replicative fitness was also observed when virus pairs were added to human dendritic cells and then cocultured with primary, quiescent T cells, which is the model for HIV-1 transmission. These results suggest that reduced replicative and transmission fitness may be contributing to the low prevalence and limited geographical spread of HIV-2 and group O HIV-1 in the human population.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D020180 Heteroduplex Analysis A method of detecting gene mutation by mixing PCR-amplified mutant and wild-type DNA followed by denaturation and reannealing. The resultant products are resolved by gel electrophoresis, with single base substitutions detectable under optimal electrophoretic conditions and gel formulations. Large base pair mismatches may also be analyzed by using electron microscopy to visualize heteroduplex regions. Analyses, Heteroduplex,Analysis, Heteroduplex,Heteroduplex Analyses

Related Publications

Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
March 2005, Journal of clinical microbiology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
November 1995, The Journal of infectious diseases,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
May 1998, Journal of virology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
May 1997, Journal of clinical microbiology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
January 1997, Journal of human virology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
December 1998, Journal of clinical microbiology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
February 2000, Journal of clinical microbiology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
December 1999, Journal of virology,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
September 1998, Nature medicine,
Kevin K Ariën, and Awet Abraha, and Miguel E Quiñones-Mateu, and Luc Kestens, and Guido Vanham, and Eric J Arts
June 2010, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!